This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haque;, D. K. N.
Right arrow Articles by Modi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haque;, D. K. N.
Right arrow Articles by Modi, N.

PEDIATRICS Vol. 105 No. 5 May 2000, pp. 1173-1174

Intravenous Immunoglobulins Versus Sepsis

The first 20% of the full text of this article appears below.

To the Editor.

It was interesting to read the paper by Carr et al (Pediatrics. 1999;103:796-802). With continuing high morbidity and mortality from neonatal sepsis, there is little doubt that there is a need for developing new effective adjunctive strategies. However, I was a little surprised at their selective use of published literature regarding the use of intravenous immunoglobulins (IVIG).

Systematic review1 of prophylactic . . . [Full Text of this Article]


This article has been cited by other articles:


Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
I Roberts and N A Murray
Neonatal thrombocytopenia: causes and management
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2003; 88(5): F359 - F364.
[Abstract] [Full Text] [PDF]